glp 1 and gip for weight loss GLP-1 & Agonists | Obesity Diabetes Management | Harrison's updates (22nd Ed.) Medscape | The investigational triple

However, while approved by the FDA for Type 2 diabetes under the brand name Mounjaro, tirzepatide is still in the late stages of the approval process for weight loss

No details were given about the placebo

This year, Lilly became the first pharmaceutical company to reach a $1 trillion stock market value, largely fueled by sales of Zepbound and Mounjaro, its peptide weight-loss and antidiabetes injectables

GLP-1 medications may have serious side effects, including possible thyroid tumors

Originally developed to treat diabetes, tirzepatide is safe and highly effective for long-term weight loss and weight management

Drug trials snapshots: Mounjaro